Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002750011 | SCV003748787 | uncertain significance | Inborn genetic diseases | 2022-10-04 | criteria provided, single submitter | clinical testing | The c.4913C>T (p.P1638L) alteration is located in exon 27 (coding exon 25) of the KMT2E gene. This alteration results from a C to T substitution at nucleotide position 4913, causing the proline (P) at amino acid position 1638 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003492818 | SCV004235947 | uncertain significance | O'Donnell-Luria-Rodan syndrome | 2023-05-23 | criteria provided, single submitter | clinical testing |